Monitor for any future filings that disclose the number of common shares outstanding prior to this offering to calculate the exact dilution percentage. Also watch for any resale registration statement filing, which would signal the investors' intent to convert and sell common shares.
Price Chart
Executive Summary
Nu-Med Plus raised $450,000 via a private placement of Series A Preferred Stock to two accredited investors and issued an additional 50,000 Series A Preferred shares to a consultant for services. The preferred shares are convertible into a total of 4,424,640 common shares, creating significant potential dilution for existing common stockholders.
Key Financial Metrics
Key Facts
- Raised $450,000 from two accredited investors via sale of 171,232 Series A Preferred shares at $2.628 per share.
- Issued 50,000 Series A Preferred shares to a consultant for services rendered.
- Full conversion of all Series A Preferred shares would yield 4,424,640 common shares (3,424,640 from investors + 1,000,000 from consultant).
- Conversion ratio is not adjusted for any future reverse stock split.
- Offering is a best efforts, no minimum offering with a maximum of $500,000 (190,258 shares).
- Investors received piggyback registration rights for two years.
- Shares were issued under Rule 506(b) of Regulation D and/or Regulation S exemption.
Financial Impact
Potential dilution of up to 4,424,640 common shares from conversion of Series A Preferred, representing a substantial increase in the common share count relative to the company's current outstanding shares.
Risk Factors
- Massive potential dilution to common shareholders from preferred share conversion.
- No minimum offering requirement means the company can operate with less than the full $500,000 raised.
- Piggyback registration rights could lead to a flood of common shares on the market.
- Company may issue additional shares at lower prices in future offerings, further diluting existing holders.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001575872-26-000709 |
| Document: numd_8k.htm | 0001575872-26-000709 |
| Document: 0001575872-26-000709-index-headers.html | 0001575872-26-000709 |
| Document: 0001575872-26-000709-index.html | 0001575872-26-000709 |
| Document: 0001575872-26-000709.txt | 0001575872-26-000709 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $0.007200 $0.007200 | · 0.00% | ▲ +0.53% | $0.007200 (+0.00%) |
Aug 25, 2026 8w ago | 8-K | $0.0244 $0.0230 | ▼ −5.74% | ▼ −5.76% | $0.007200 (−70.49%) |
Jun 30, 2026 16w ago | 8-K | $0.0116 $0.0130 | ▲ +12.26% | ▲ +12.40% | $0.007200 (−37.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers